60th Annual Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis
The purpose of the SSC Meeting is to bring together the world leaders to identify unmet issues with identifying bleeding than clotting disorders and to cooperatively study and standardize the approaches to these disorders. The SSC consists of 19 Subcommittees and one Working Group that are organized around the various components of the hemostatic process. This will be the 60th meeting of this organization. On the first day of the meeting, we will deal with an education and learning program for trainees and their role in engaging the mentoring process as an active participant. The Plenary Session will deal with the Role of Genomics and Personalized Medicine in patients with hereditary and acquired thrombotic and hemorrhagic diseases. Each of the 19 Subcommittees will have one or two four hour meetings with education, research status reports and identification of gaps in our understanding or standardization practices that need to be further addressed by the Subcommittee members. Additional cross-discipline Educational Sessions will address worldwide unmet problems that involve hemostatic issues with Sickle Cell Disease and a separate session on Malaria.
The evolving areas of science, developing diagnostics, and therapeutic products mandate standardized understanding and nomenclature. We work with the WHO to establish the defined standard reference materials that are needed to define measurement of biological activities that permit the communication of medical testing and information between physicians, between hospitals, and between geographic areas of the world.
Promote improved standardized approaches to the diagnosis, clinical assessment of treatment, and even recognition of new diseases or disease mechanisms at an international level of understanding.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis (ISTH). The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 9.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 9.0 hours of participation for continuing education for allied health professionals.
1.Discuss the foundation for international standardization of clinical disorders.
2.Utilize new technologies to address the clinical assessment and treatment of bleeding and clotting disorders.
3.Improve communication with international leaders to improve the diagnosis and treatment of bleeding and clotting disorders with medical inequities exist in the World.
Robert R. Montgomery, MD
Blood Center of Wisconsin, Inc
Professor of Pediatrics - The Medical College of Wisconsin
Children's Hosptial of Wisconsin
- 9.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 9.00 Hours of ParticipationHours of Participation credit.